TCIM
TIAA CREF Investment Management’s CVS Health CVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $369M | Sell |
6,842,868
-1,768,121
| -21% | -$95.4M | 0.26% | 75 |
|
|
2018
Q4 | $564M | Buy |
8,610,989
+2,226,239
| +35% | +$146M | 0.45% | 43 |
|
|
2018
Q3 | $503M | Buy |
6,384,750
+971,325
| +18% | +$76.5M | 0.33% | 64 |
|
|
2018
Q2 | $348M | Buy |
5,413,425
+2,359,028
| +77% | +$152M | 0.23% | 91 |
|
|
2018
Q1 | $190M | Buy |
3,054,397
+92,262
| +3% | +$5.74M | 0.13% | 167 |
|
|
2017
Q4 | $215M | Sell |
2,962,135
-250,151
| -8% | -$18.1M | 0.14% | 153 |
|
|
2017
Q3 | $261M | Buy |
3,212,286
+151,714
| +5% | +$12.3M | 0.18% | 123 |
|
|
2017
Q2 | $246M | Sell |
3,060,572
-1,369,719
| -31% | -$110M | 0.17% | 131 |
|
|
2017
Q1 | $348M | Sell |
4,430,291
-1,239,278
| -22% | -$97.3M | 0.25% | 84 |
|
|
2016
Q4 | $447M | Sell |
5,669,569
-229,329
| -4% | -$18.1M | 0.33% | 61 |
|
|
2016
Q3 | $525K | Sell |
5,898,898
-920,982
| -14% | -$82K | 0.33% | 67 |
|
|
2016
Q2 | $653M | Buy |
6,819,880
+51,493
| +0.8% | +$4.93M | 0.5% | 44 |
|
|
2016
Q1 | $702M | Sell |
6,768,387
-591,180
| -8% | -$61.3M | 0.54% | 38 |
|
|
2015
Q4 | $720M | Sell |
7,359,567
-1,087,380
| -13% | -$106M | 0.54% | 36 |
|
|
2015
Q3 | $815M | Sell |
8,446,947
-403,272
| -5% | -$38.9M | 0.64% | 25 |
|
|
2015
Q2 | $928M | Sell |
8,850,219
-361
| -0% | -$37.9K | 0.66% | 24 |
|
|
2015
Q1 | $913M | Buy |
8,850,580
+201,512
| +2% | +$20.8M | 0.64% | 27 |
|
|
2014
Q4 | $833M | Buy |
8,649,068
+60,675
| +0.7% | +$5.84M | 0.58% | 28 |
|
|
2014
Q3 | $684M | Buy |
8,588,393
+262,295
| +3% | +$20.9M | 0.49% | 38 |
|
|
2014
Q2 | $628M | Buy |
8,326,098
+1,475,947
| +22% | +$111M | 0.44% | 41 |
|
|
2014
Q1 | $513M | Buy |
6,850,151
+362,242
| +6% | +$27.1M | 0.37% | 49 |
|
|
2013
Q4 | $464M | Buy |
6,487,909
+912,980
| +16% | +$65.3M | 0.33% | 57 |
|
|
2013
Q3 | $316M | Sell |
5,574,929
-171,494
| -3% | -$9.73M | 0.25% | 85 |
|
|
2013
Q2 | $329M | Buy |
+5,746,423
| New | +$329M | 0.27% | 82 |
|